These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 9255233

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Growth hormone and cardiac function.
    Lombardi G, Di Somma C, Marzullo P, Cerbone G, Colao A.
    Ann Endocrinol (Paris); 2000 Feb; 61(1):16-21. PubMed ID: 10790587
    [Abstract] [Full Text] [Related]

  • 23. The heart: an end-organ of GH action.
    Colao A, Vitale G, Pivonello R, Ciccarelli A, Di Somma C, Lombardi G.
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S93-101. PubMed ID: 15339252
    [Abstract] [Full Text] [Related]

  • 24. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H.
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [Abstract] [Full Text] [Related]

  • 25. [Clinical and metabolic effects of recombinant human growth hormone in cardiac insufficiency].
    Modlińska A, Babińska A, Faran G, Sworczak K.
    Przegl Lek; 2003 Apr; 60(5):349-52. PubMed ID: 14593678
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age.
    Kappelgaard AM, Laursen T.
    Growth Horm IGF Res; 2011 Dec; 21(6):305-13. PubMed ID: 22019012
    [Abstract] [Full Text] [Related]

  • 29. Pharmacologic therapy in growth hormone disorders and the heart.
    Climent V, Marín F, Picó A.
    Curr Med Chem; 2007 Dec; 14(13):1399-407. PubMed ID: 17584052
    [Abstract] [Full Text] [Related]

  • 30. [Growth hormone secretion in heart failure].
    Giustina A, Bonadonna S, Burattin A, Manelli F, Lorusso R, Volterrani M, Villa S, Dei Cas L, Agabiti Rosei E.
    Minerva Endocrinol; 2003 Mar; 28(1):1-11. PubMed ID: 12621359
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cardiovascular disease and risk factors: the role of growth hormone.
    Isgaard J.
    Horm Res; 2004 Mar; 62 Suppl 4():31-8. PubMed ID: 15591764
    [Abstract] [Full Text] [Related]

  • 33. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [Abstract] [Full Text] [Related]

  • 34. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Sowinski J, Wysocki H.
    Int J Cardiol; 2005 May 25; 101(2):257-63. PubMed ID: 15882673
    [Abstract] [Full Text] [Related]

  • 35. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E, Lucci R, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Nov 25; 84(11):3950-5. PubMed ID: 10566633
    [Abstract] [Full Text] [Related]

  • 36. Growth hormone: a new therapy for heart failure?
    Saccà L.
    Baillieres Clin Endocrinol Metab; 1998 Jul 25; 12(2):217-31. PubMed ID: 10083893
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone therapy in children and adults.
    Krysiak R, Gdula-Dymek A, Bednarska-Czerwińska A, Okopień B.
    Pharmacol Rep; 2007 Jul 25; 59(5):500-16. PubMed ID: 18048950
    [Abstract] [Full Text] [Related]

  • 38. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
    Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte AM, Pivonello R, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2001 Apr 25; 86(4):1551-7. PubMed ID: 11297582
    [Abstract] [Full Text] [Related]

  • 39. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Florimonte L, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Jan 25; 84(1):17-23. PubMed ID: 9920056
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.